SCHEMBL7936451

SCHEMBL7936451

CCCCC(CC)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12855699 1.00
SCHEMBL21557 0.92 EPHX1 (0.42)
SCHEMBL30436843 0.90 EPHX1 (0.46)
SCHEMBL20840762 0.90 EPHX1 (0.46)
SCHEMBL13932787 0.90 EPHX1 (0.46)
SCHEMBL8332892 0.90 EPHX1 (0.46)
SCHEMBL117988 0.90 EPHX1 (0.46)
SCHEMBL10700618 0.90 EPHX1 (0.46)
Hydrochloric Acid SCHEMBL28052855 0.90 EPHX1 (0.40)
SCHEMBL27325560 0.90 EPHX1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4491671-A Process for the preparation of N-substituted imido-dicarboxylic acid diaryl esters BAYER AKTIENGESELLSCHAFT (DE) 1985-01-01 US claimed
CN-117510500-A Preparation method of asperazepanones alkaloid and application of asperazepanones alkaloid as anti-inflammatory drug 中国海洋大学 2024-02-06 CN disclosed
EP-4289951-A2 CIRCULAR RNA COMPOSITIONS AND METHODS Orna Therapeutics, Inc. (US) 2023-12-13 EP disclosed
CN-117050043-A 3-phenyl dibenzofuran compound and preparation method and application thereof 中国海洋大学 2023-11-14 CN disclosed
CN-116726010-A Application of macrolide derivative in preparation of medicines for inhibiting pro-inflammatory cytokine acting agents 中国海洋大学 2023-09-12 CN disclosed
US-20230173024-A1 FACTOR B INHIBITORS AND USES THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2023-06-08 US disclosed
CN-112851622-B Macrolide brefeldin A ester derivative and application thereof 中国海洋大学 2023-01-10 CN disclosed
CN-112851622-A Macrolide brefeldin A ester derivative and application thereof 中国海洋大学 2021-05-28 CN disclosed
EP-3041841-B1 TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2019-06-05 EP disclosed
US-10274824-B2 Photobase generators and photoresist compositions comprising same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2019-04-30 US disclosed
US-20140057907-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS, INC. (US) 2014-02-27 US disclosed
WO-2010027097-A1 TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-11 WO disclosed
EP-2105146-A1 Nucleic-acid triggered release of molecules Riken (JP) 2009-09-30 EP disclosed
EP-1670757-B1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS LILLY CO ELI (US) 2009-05-06 EP disclosed
EP-1422260-B1 Curable fluoropolyether rubber compositions and rubber articles SHINETSU CHEMICAL CO (JP) 2008-12-31 EP disclosed
EP-1950199-A1 Proline derivatives and use thereof as drugs Mitsubishi Tanabe Pharma Corporation (JP) 2008-07-30 EP disclosed
US-20080107608-A1 5-Substituted-2-Arylpyridines GE PING 2008-05-08 US disclosed
US-7329663-B2 Substituted-triazolopyrimidines as anticancer agents WYETH (US) 2008-02-12 US disclosed
US-7223778-B2 5-substituted-2-arylpyridines NEUROGEN CORPORATION (US) 2007-05-29 US disclosed
EP-1606380-B1 DETERGENT COMPOSITIONS CIBA SC HOLDING AG (CH) 2007-04-11 EP disclosed